Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial

IMPORTANCE: Contemporary clinical trials of heart failure with preserved ejection fraction (HFpEF) apply natriuretic peptide (NP) thresholds to identify patients who are more likely to have the disease of interest and to enrich the baseline risk of the enrolled cohort. OBJECTIVE: To determine whethe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Cardiol
Main Authors: Myhre, Peder Langeland, Vaduganathan, Muthiah, Claggett, Brian L., Anand, Inder S., Sweitzer, Nancy K., Fang, James C., O'Meara, Eileen, Shah, Sanjiv J., Desai, Akshay S., Lewis, Eldrin F., Rouleau, Jean, Pitt, Bertram, Pfeffer, Marc A., Solomon, Scott D.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2018
Assuntos:
Brief Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233827/
https://ncbi.nlm.nih.gov/pubmed/30140899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2018.2568
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares